268 related articles for article (PubMed ID: 29165831)
21. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems.
Tannus RK; Almeida-Carvalho SR; Loureiro-Matos CA; Miziara-Gonzalez A; Salzedas-Netto AA; Szejnfeld D; D'Ippolito G; Pereira-Lanzoni V; Souza-Silva I
PLoS One; 2018; 13(4):e0194922. PubMed ID: 29617435
[TBL] [Abstract][Full Text] [Related]
22. The Prognostic Ability of Major Hepatocellular Carcinoma Staging Systems Is Improved by Including a Treatment Variable.
Wallace MC; Knuiman M; Huang Y; Garas G; Adams LA; MacQuillan G; Preen DB; Jeffrey GP
Dig Dis Sci; 2018 Sep; 63(9):2277-2284. PubMed ID: 29808245
[TBL] [Abstract][Full Text] [Related]
23. Staging systems of hepatocellular carcinoma: A review.
Tellapuri S; Sutphin PD; Beg MS; Singal AG; Kalva SP
Indian J Gastroenterol; 2018 Nov; 37(6):481-491. PubMed ID: 30593649
[TBL] [Abstract][Full Text] [Related]
24. Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area.
Lee JH; Kim HY; Kim YJ; Yoon JH; Chung JW; Lee HS
J Gastroenterol Hepatol; 2015 Apr; 30(4):696-705. PubMed ID: 25250761
[TBL] [Abstract][Full Text] [Related]
25. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.
Kudo M; Chung H; Haji S; Osaki Y; Oka H; Seki T; Kasugai H; Sasaki Y; Matsunaga T
Hepatology; 2004 Dec; 40(6):1396-405. PubMed ID: 15565571
[TBL] [Abstract][Full Text] [Related]
26. Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature.
Campigotto M; Giuffrè M; Colombo A; Visintin A; Aversano A; Budel M; Masutti F; Abazia C; Crocé LS
World J Hepatol; 2020 Dec; 12(12):1239-1257. PubMed ID: 33442451
[TBL] [Abstract][Full Text] [Related]
27. Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective.
Li JW; Goh BG; Chang PE; Tan CK
World J Gastroenterol; 2017 Jun; 23(22):4054-4063. PubMed ID: 28652658
[TBL] [Abstract][Full Text] [Related]
28. Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma.
Wang JH; Kee KM; Lin CY; Hung CH; Chen CH; Lee CM; Lu SN
J Gastroenterol Hepatol; 2015 Feb; 30(2):358-63. PubMed ID: 25088668
[TBL] [Abstract][Full Text] [Related]
29. A new prognostic score can predict survival after hepatocellular carcinoma treatment in a cohort of 1302 Egyptian hepatocellular carcinoma patients.
Abdelaziz AO; Shousha HI; Abdelmaksoud AH; Saad Y; Elbaz TM; Soliman ZA; Salah A; Lithy R; Ahmed M; Nabil MM
Eur J Gastroenterol Hepatol; 2018 May; 30(5):514-519. PubMed ID: 29465472
[TBL] [Abstract][Full Text] [Related]
30. The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular Carcinoma.
Op den Winkel M; Nagel D; Op den Winkel P; Paprottka PM; Schmidt L; Bourhis H; Trojan J; Goeller M; Reiter FP; Stecher SS; De Toni EN; Gerbes AL; Kolligs FT
Digestion; 2019; 100(1):15-26. PubMed ID: 30282074
[TBL] [Abstract][Full Text] [Related]
31. Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.
op den Winkel M; Nagel D; Sappl J; op den Winkel P; Lamerz R; Zech CJ; Straub G; Nickel T; Rentsch M; Stieber P; Göke B; Kolligs FT
PLoS One; 2012; 7(10):e45066. PubMed ID: 23071507
[TBL] [Abstract][Full Text] [Related]
32. Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Bucci L; Garuti F; Camelli V; Lenzi B; Farinati F; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Maida M; Felder M; Morisco F; Gasbarrini A; Gemini S; Foschi FG; Missale G; Masotto A; Affronti A; Bernardi M; Trevisani F; ;
Aliment Pharmacol Ther; 2016 Feb; 43(3):385-99. PubMed ID: 26662476
[TBL] [Abstract][Full Text] [Related]
33. Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization.
Georgiades CS; Liapi E; Frangakis C; Park JU; Kim HW; Hong K; Geschwind JF
J Vasc Interv Radiol; 2006 Oct; 17(10):1619-24. PubMed ID: 17057003
[TBL] [Abstract][Full Text] [Related]
34. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.
Li X; Dong M; Lin Q; Chen ZH; Ma XK; Xing YF; Wan XB; Wen JY; Wei L; Chen J; Wu XY
Asia Pac J Clin Oncol; 2013 Mar; 9(1):86-92. PubMed ID: 23279888
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Cho YK; Chung JW; Kim JK; Ahn YS; Kim MY; Park YO; Kim WT; Byun JH
Cancer; 2008 Jan; 112(2):352-61. PubMed ID: 18008352
[TBL] [Abstract][Full Text] [Related]
36. Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score.
Chung H; Kudo M; Takahashi S; Hagiwara S; Sakaguchi Y; Inoue T; Minami Y; Ueshima K; Fukunaga T; Matsunaga T
J Gastroenterol Hepatol; 2008 Mar; 23(3):445-52. PubMed ID: 17683486
[TBL] [Abstract][Full Text] [Related]
37. Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score.
Op den Winkel M; Nagel D; Op den Winkel P; Trojan J; Paprottka PM; Steib CJ; Schmidt L; Göller M; Stieber P; Göhring P; Herbst A; Rentsch M; De Toni EN; Göke B; Gerbes AL; Kolligs FT
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):44-53. PubMed ID: 29076939
[TBL] [Abstract][Full Text] [Related]
38. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.
Vitale A; Burra P; Frigo AC; Trevisani F; Farinati F; Spolverato G; Volk M; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Svegliati Baroni G; Virdone R; Cillo U;
J Hepatol; 2015 Mar; 62(3):617-24. PubMed ID: 25450706
[TBL] [Abstract][Full Text] [Related]
39. Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.
Gomaa AI; Hashim MS; Waked I
PLoS One; 2014; 9(3):e90929. PubMed ID: 24603710
[TBL] [Abstract][Full Text] [Related]
40. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
